Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein.

Authors:
Salem R; El-Kholy AA; Waly FR; Ayman D; Sakr A and 1 more

Journal:
Mol Immunol

Publication Year: 2021

DOI:
10.1016/j.molimm.2021.12.006

PMCID:
PMC8660258

PMID:
34915268

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mol Immunol

Abbreviation: Mol Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.
Purbey PK; Roy K; Gupta S and 1 more (2023) - Transparency Score: 1/6
Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure…
Badano MN; Sabbione F; Keitelman I and 12 more (2022) - Transparency Score: 3/6
Identification of virus-specific B-cell epitopes by convalescent plasma from COVID-19 patients.
Wang L; Zhao J; Schank M and 13 more (2022) - Transparency Score: 4/6
Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluat…
de Castro Barbosa E; de Souza Andrade A; Duarte MM and 7 more (2022) - Transparency Score: 3/6
Synergism of TNF-α and IFN-β triggers human airway epithelial cells death by apoptosis and pyroptos…
Sun R; Jiang K; Zeng C and 4 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding This study was financially supported by Science, Technology & Innovation Funding Authority (STIFA), Egypt; Emergency Targeted Program; COVID -19 Emergency call, Project ID: 43798"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025